Skip to main content
. 2021 Feb 18;10(4):825. doi: 10.3390/jcm10040825
ACE-i angiotensin-converting enzyme inhibitor
ACS acute coronary syndrome
ADL activities of daily living
APTT activated partial thromboplastin time
ARB angiotensin II receptor blocker
AUC area under the curve
AVK antivitamin K
BP blood pressure
BUN blood urea nitrogen
CAD coronary artery disease
CI confidence interval
CKD chronic kidney disease
COPD chronic obstructive pulmonary disease
CPD chronic pulmonary disease
CRP C-reactive protein
CRT cardiac resynchronization therapy
CTA computed tomography angiography
CVRF cardiovascular risk factor
CURB-65 confusion, BUN, respiratory rate, systolic blood pressure, age ≥ 65
DOAC direct oral anticoagulant
DVT deep venous thrombosis
ECG electrocardiogram
ED emergency department
HCQ hydroxychloroquine
ICD implantable cardiac device
ICU intensive care unit
INR international normalized ratio
IQR interquartile range
LVEF left ventricular ejection fraction
MI myocardial infarction
MRA mineralocorticoid receptor antagonist
no number
OAD oral antidiabetic
OSAS obstructive sleep apnea syndrome
OR odds ratio
PE pulmonary embolism
RAAS renin-angiotensin-aldosterone system
ROC receiver operating characteristic
RT-PCR reverse transcriptase-polymerase chain reaction
SARS-CoV-2 severe acute respiratory syndrome coronavirus 2
SD standard deviation
SE standard error
TIA transient ischaemic attack
TnI troponin I
T2DM type-2 diabetes mellitus
SARS-CoV-2 severe acute respiratory syndrome-coronavirus 2